Emerging non-canonical functions and regulation by p53: p53 and stemness

David J. Olivos, Lindsey Mayo

Research output: Contribution to journalReview article

16 Citations (Scopus)

Abstract

Since its discovery nearly 40 years ago, p53 has ascended to the forefront of investigated genes and proteins across diverse research disciplines and is recognized most exclusively for its role in cancer as a tumor suppressor. Levine and Oren (2009) reviewed the evolution of p53 detailing the significant discoveries of each decade since its first report in 1979. In this review, we will highlight the emerging non-canonical functions and regulation of p53 in stem cells. We will focus on general themes shared among p53’s functions in non-malignant stem cells and cancer stem-like cells (CSCs) and the influence of p53 on the microenvironment and CSC niche. We will also examine p53 gain of function (GOF) roles in stemness. Mutant p53 (mutp53) GOFs that lead to survival, drug resistance and colonization are reviewed in the context of the acquisition of advantageous transformation processes, such as differentiation and dedifferentiation, epithelial-to-mesenchymal transition (EMT) and stem cell senescence and quiescence. Finally, we will conclude with therapeutic strategies that restore wild-type p53 (wtp53) function in cancer and CSCs, including RING finger E3 ligases and CSC maintenance. The mechanisms by which wtp53 and mutp53 influence stemness in non-malignant stem cells and CSCs or tumor-initiating cells (TICs) are poorly understood thus far. Further elucidation of p53’s effects on stemness could lead to novel therapeutic strategies in cancer research.

Original languageEnglish (US)
Article number1982
JournalInternational Journal of Molecular Sciences
Volume17
Issue number12
DOIs
StatePublished - Dec 1 2016

Fingerprint

Neoplastic Stem Cells
stem cells
Stem cells
emerging
cancer
Tumors
Stem Cells
Ubiquitin-Protein Ligases
Neoplasms
Stem Cell Niche
Epithelial-Mesenchymal Transition
Genes
Cell Aging
tumors
Proteins
Mesenchymal Stromal Cells
Research
Drug Resistance
suppressors
Maintenance

Keywords

  • Cancer stem cell (CSC)
  • Colonization
  • Mdm2
  • Mutant p53
  • Niche
  • Non-canonical function
  • Normal stem cells
  • P53
  • Regulation
  • Survival
  • Translational modifications

ASJC Scopus subject areas

  • Catalysis
  • Molecular Biology
  • Computer Science Applications
  • Spectroscopy
  • Physical and Theoretical Chemistry
  • Organic Chemistry
  • Inorganic Chemistry

Cite this

Emerging non-canonical functions and regulation by p53 : p53 and stemness. / Olivos, David J.; Mayo, Lindsey.

In: International Journal of Molecular Sciences, Vol. 17, No. 12, 1982, 01.12.2016.

Research output: Contribution to journalReview article

@article{a10320edf4834150b4269f946503a68f,
title = "Emerging non-canonical functions and regulation by p53: p53 and stemness",
abstract = "Since its discovery nearly 40 years ago, p53 has ascended to the forefront of investigated genes and proteins across diverse research disciplines and is recognized most exclusively for its role in cancer as a tumor suppressor. Levine and Oren (2009) reviewed the evolution of p53 detailing the significant discoveries of each decade since its first report in 1979. In this review, we will highlight the emerging non-canonical functions and regulation of p53 in stem cells. We will focus on general themes shared among p53’s functions in non-malignant stem cells and cancer stem-like cells (CSCs) and the influence of p53 on the microenvironment and CSC niche. We will also examine p53 gain of function (GOF) roles in stemness. Mutant p53 (mutp53) GOFs that lead to survival, drug resistance and colonization are reviewed in the context of the acquisition of advantageous transformation processes, such as differentiation and dedifferentiation, epithelial-to-mesenchymal transition (EMT) and stem cell senescence and quiescence. Finally, we will conclude with therapeutic strategies that restore wild-type p53 (wtp53) function in cancer and CSCs, including RING finger E3 ligases and CSC maintenance. The mechanisms by which wtp53 and mutp53 influence stemness in non-malignant stem cells and CSCs or tumor-initiating cells (TICs) are poorly understood thus far. Further elucidation of p53’s effects on stemness could lead to novel therapeutic strategies in cancer research.",
keywords = "Cancer stem cell (CSC), Colonization, Mdm2, Mutant p53, Niche, Non-canonical function, Normal stem cells, P53, Regulation, Survival, Translational modifications",
author = "Olivos, {David J.} and Lindsey Mayo",
year = "2016",
month = "12",
day = "1",
doi = "10.3390/ijms17121982",
language = "English (US)",
volume = "17",
journal = "International Journal of Molecular Sciences",
issn = "1661-6596",
publisher = "Multidisciplinary Digital Publishing Institute (MDPI)",
number = "12",

}

TY - JOUR

T1 - Emerging non-canonical functions and regulation by p53

T2 - p53 and stemness

AU - Olivos, David J.

AU - Mayo, Lindsey

PY - 2016/12/1

Y1 - 2016/12/1

N2 - Since its discovery nearly 40 years ago, p53 has ascended to the forefront of investigated genes and proteins across diverse research disciplines and is recognized most exclusively for its role in cancer as a tumor suppressor. Levine and Oren (2009) reviewed the evolution of p53 detailing the significant discoveries of each decade since its first report in 1979. In this review, we will highlight the emerging non-canonical functions and regulation of p53 in stem cells. We will focus on general themes shared among p53’s functions in non-malignant stem cells and cancer stem-like cells (CSCs) and the influence of p53 on the microenvironment and CSC niche. We will also examine p53 gain of function (GOF) roles in stemness. Mutant p53 (mutp53) GOFs that lead to survival, drug resistance and colonization are reviewed in the context of the acquisition of advantageous transformation processes, such as differentiation and dedifferentiation, epithelial-to-mesenchymal transition (EMT) and stem cell senescence and quiescence. Finally, we will conclude with therapeutic strategies that restore wild-type p53 (wtp53) function in cancer and CSCs, including RING finger E3 ligases and CSC maintenance. The mechanisms by which wtp53 and mutp53 influence stemness in non-malignant stem cells and CSCs or tumor-initiating cells (TICs) are poorly understood thus far. Further elucidation of p53’s effects on stemness could lead to novel therapeutic strategies in cancer research.

AB - Since its discovery nearly 40 years ago, p53 has ascended to the forefront of investigated genes and proteins across diverse research disciplines and is recognized most exclusively for its role in cancer as a tumor suppressor. Levine and Oren (2009) reviewed the evolution of p53 detailing the significant discoveries of each decade since its first report in 1979. In this review, we will highlight the emerging non-canonical functions and regulation of p53 in stem cells. We will focus on general themes shared among p53’s functions in non-malignant stem cells and cancer stem-like cells (CSCs) and the influence of p53 on the microenvironment and CSC niche. We will also examine p53 gain of function (GOF) roles in stemness. Mutant p53 (mutp53) GOFs that lead to survival, drug resistance and colonization are reviewed in the context of the acquisition of advantageous transformation processes, such as differentiation and dedifferentiation, epithelial-to-mesenchymal transition (EMT) and stem cell senescence and quiescence. Finally, we will conclude with therapeutic strategies that restore wild-type p53 (wtp53) function in cancer and CSCs, including RING finger E3 ligases and CSC maintenance. The mechanisms by which wtp53 and mutp53 influence stemness in non-malignant stem cells and CSCs or tumor-initiating cells (TICs) are poorly understood thus far. Further elucidation of p53’s effects on stemness could lead to novel therapeutic strategies in cancer research.

KW - Cancer stem cell (CSC)

KW - Colonization

KW - Mdm2

KW - Mutant p53

KW - Niche

KW - Non-canonical function

KW - Normal stem cells

KW - P53

KW - Regulation

KW - Survival

KW - Translational modifications

UR - http://www.scopus.com/inward/record.url?scp=85000460046&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85000460046&partnerID=8YFLogxK

U2 - 10.3390/ijms17121982

DO - 10.3390/ijms17121982

M3 - Review article

C2 - 27898034

AN - SCOPUS:85000460046

VL - 17

JO - International Journal of Molecular Sciences

JF - International Journal of Molecular Sciences

SN - 1661-6596

IS - 12

M1 - 1982

ER -